BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20010311)

  • 1. Multidrug-resistant Enterococcus faecium meningitis in a toddler: characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline.
    Jaspan HB; Brothers AW; Campbell AJ; McGuire JK; Browd SR; Manley TJ; Pak D; Weissman SJ
    Pediatr Infect Dis J; 2010 Apr; 29(4):379-81. PubMed ID: 20010311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug-resistant Enterococcus faecium endocarditis treated with combination tigecycline and high-dose daptomycin.
    Schutt AC; Bohm NM
    Ann Pharmacother; 2009 Dec; 43(12):2108-12. PubMed ID: 19887592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin.
    Jenkins I
    J Hosp Med; 2007 Sep; 2(5):343-4. PubMed ID: 17935250
    [No Abstract]   [Full Text] [Related]  

  • 4. Meningitis due to vancomycin-resistant Enterococcus faecium successfully treated with combined intravenous and intraventricular chloramphenicol.
    Scapellato PG; Ormazabal C; Scapellato JL; Bottaro EG
    J Clin Microbiol; 2005 Jul; 43(7):3578-9. PubMed ID: 16000513
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy.
    Le J; Bookstaver PB; Rudisill CN; Hashem MG; Iqbal R; James CL; Sakoulas G
    Ann Pharmacother; 2010 Dec; 44(12):2001-6. PubMed ID: 21119097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin-resistant Enterococcus faecium (VRE) bacteremia in infective endocarditis successfully treated with combination daptomycin and tigecycline.
    Polidori M; Nuccorini A; Tascini C; Gemignani G; Iapoce R; Leonildi A; Tagliaferri E; Menichetti F
    J Chemother; 2011 Aug; 23(4):240-1. PubMed ID: 21803704
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin-resistant Enterococcus faecium.
    Mueller SW; Kiser TH; Anderson TA; Neumann RT
    Ann Pharmacother; 2012 Dec; 46(12):e35. PubMed ID: 23232018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistant Acinetobacter nosocomial meningitis treated successfully with parenteral tigecycline.
    Wadi JA; Al Rub MA
    Ann Saudi Med; 2007; 27(6):456-8. PubMed ID: 18059130
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of vancomycin treatment for meningitis caused by vancomycin-susceptible Enterococcus faecium.
    van Overbeek EC; Janknegt R; Ter Berg HW; Top J; Sportel E; Heddema ER
    Scand J Infect Dis; 2010 Oct; 42(10):794-6. PubMed ID: 20491535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricular Plus Intravenous Tigecycline for the Treatment of Daptomycin Nonsusceptible Vancomycin-Resistant Enterococci in an Infant with Ventriculoperitoneal Shunt Infection.
    Şahin A; Dalgic N
    World Neurosurg; 2019 Oct; 130():470-473. PubMed ID: 31302272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
    Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ
    J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin-resistant Enterococcus faecium meningitis in adults: case series and review of the literature.
    Knoll BM; Hellmann M; Kotton CN
    Scand J Infect Dis; 2013 Feb; 45(2):131-9. PubMed ID: 22992165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature.
    Zeana C; Kubin CJ; Della-Latta P; Hammer SM
    Clin Infect Dis; 2001 Aug; 33(4):477-82. PubMed ID: 11462183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy for disseminated strongyloidiasis with associated vancomycin-resistant, linezolid-intermediate Enterococcus faecium meningitis: A case report.
    Tobin MA; Dougherty DF; Ratliff PD; Judd WR
    J Clin Pharm Ther; 2022 Jan; 47(1):121-124. PubMed ID: 34075617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Considerations for CNS Infections Caused by Vancomycin-Resistant
    Lee BJ; Vu BN; Seddon AN; Hodgson HA; Wang SK
    Ann Pharmacother; 2020 Dec; 54(12):1243-1251. PubMed ID: 32506921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin-resistant Enterococcus spp.: validation of susceptibility testing and in vitro activity of vancomycin, linezolid, tigecycline and daptomycin.
    Rathe M; Kristensen L; Ellermann-Eriksen S; Thomsen MK; Schumacher H
    APMIS; 2010 Jan; 118(1):66-73. PubMed ID: 20041873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraventricular administration of tigecycline for the treatment of multidrug-resistant bacterial meningitis after craniotomy: a case report.
    Wu Y; Chen K; Zhao J; Wang Q; Zhou J
    J Chemother; 2018 Feb; 30(1):49-52. PubMed ID: 28614982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia.
    Kvirikadze N; Suseno M; Vescio T; Kaminer L; Singh K
    Scand J Infect Dis; 2006; 38(4):290-2. PubMed ID: 16709529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
    Dowzicky MJ
    Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium.
    Abb J
    Int J Antimicrob Agents; 2007 Mar; 29(3):358-60. PubMed ID: 17229553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.